Sign in
4

Changes in Ownership

FATE THERAPEUTICS INC Filed Acc 0001104659-23-048557

Director bought 276,639 shares at an average $6.17 ($1,705,829)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Redmile Group, LLC Director 2023-04-20 Purchase +20,000 $5.99 $119,800 12,879,119 I
Redmile Group, LLC Director 2023-04-21 Purchase +256,639 $6.18 $1,586,029 13,135,758 I
Open-market purchases · 276,639 sh · avg $6.17 · $1,705,829
Loading xslF345X04/tm2313419-7_4seq1.xml…